Premium
Impact of Bispectral Index for monitoring propofol remifentanil anaesthesia. A randomised clinical trial
Author(s) -
BRESIL P.,
NIELSSON M. S.,
MALVER L. P.,
KRÆMER K.,
SCHJØRRING O.,
DETHLEFSEN C.,
LAMBERT P. H.
Publication year - 2013
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/aas.12158
Subject(s) - medicine , bispectral index , remifentanil , propofol , anesthesia , randomized controlled trial , intraoperative awareness , clinical trial , surgery
Previous research has shown that the use of the bispectral index (BIS) monitor to measure the depth of anaesthesia reduces the amount of anaesthetics administered and the recovery time from general anaesthesia. The effect of BIS on recovery from anaesthesia and consumption of anaesthetics in a paediatric population receiving total intravenous anaesthesia (TIVA) with propofol and remifentanil has not been studied.